1
Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms
Condition(s):Gastroesophageal Reflux Disease With Dyspepsia SymptomsLast Updated:September 27, 2016Completed
Lansoprazole as an Intervention: 286 Clinical Trials, Page 1 of 29
Hide Studies Not Open or Pending
2
Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]
Condition(s):Gastric Ulcer, Duodenal Ulcer, Acute Stress Gastritis, and Acute Gastric Mucosal LesionsLast Updated:February 23, 2016Completed
3
Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]
Condition(s):Acute Stress Ulcer and Acute Gastric Mucosal LesionsLast Updated:March 8, 2016Completed
4
Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions
Condition(s):HealthyLast Updated:January 5, 2011Completed
5
Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin
Condition(s):Gastric or Duodenal UlcersLast Updated:November 4, 2016Completed
6
Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs
Condition(s):Gastric or Duodenal UlcersLast Updated:October 27, 2016Completed
7
Lansoprazole in Preterm Infants With Reflux
Condition(s):Preterm Infants; Gastrointestinal RefluxLast Updated:September 13, 2013Completed
8
Lansoprazole for Subgroups of Functional Dyspepsia
Condition(s):Functional DyspepsiaLast Updated:April 15, 2014Terminated
9
Pharmacokinetic Study of Lansoprazole Capsules in Healthy Chinese Volunteer
Condition(s):Effect of Drugs; Safety IssuesLast Updated:August 15, 2019Completed
10
Safety and Efficacy of Lansoprazole in Patients With Reflux Disease
Condition(s):Gastroesophageal RefluxLast Updated:September 3, 2012Completed